https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-Highlights-ZURAMPIC-lesinurad-Phase-III-Extension-Study-Data-at-the-American-College-of-Rheumatology-2016-Annual-Meeting/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- November 13, 2016